User Tag List

Results 1 to 4 of 4

Thread: Treating PTSD with extasy/molly

  1. #1
    Senior Member V.I.P Achievements:
    50000 Experience PointsTagger Second ClassSocial1 year registered
    Overall activity: 63.0%

    Big Dummy's Avatar
    Join Date
    Jul 2016
    Posts
    13,148
    Thanks
    24,745
    Thanked: 13,792
    Rep Power
    21474852

    Treating PTSD with extasy/molly

    We are writing in response to the recent Medscape video presentation by Dr Jeffrey A. Lieberman, Misplaced Ecstasy? Questioning the Role of Psychedelics as Therapy. In this commentary, Lieberman expresses concern over a perceived, "movement to reintroduce or reevaluate the potential use of psychedelic drugs, MDMA included."

    We firmly agree that, like any other treatment, MDMA should be investigated with rigor and care, and its acceptance based on results from randomized, controlled clinical trials. Most of Lieberman's concern is directed toward the use of MDMA, because it can produce euphoria and, thus, has some abuse liability. However, his statements do not accurately reflect findings from phase 1 and 2 studies of MDMA in clinical settings, nor its proposed mechanism of action as an adjunct to therapy.
    They also do not describe the research paradigm followed by the Multidisciplinary Association for Psychedelic Studies (MAPS). Phase 2 clinical trials of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder (PTSD) have shown promising safety and efficacy outcomes, leading the US Food and Drug Administration (FDA) to grant "breakthrough therapy" designation for this investigational treatment in August 2017.

    Assisting Therapy, not Producing Euphoria

    The hypothesized mechanisms underlying the effectiveness of MDMA-assisted psychotherapy to treat PTSD are not based on its producing euphoria, but rather on its capacity to make confronting trauma-related thoughts, feelings, and memories more tolerable during therapeutic processing with support of a co-therapy team. MDMA is a monoamine releaser, but unlike stimulants, it preferentially releases serotonin, followed by norepinephrine and dopamine.[1,2,3] This difference matters, because it fundamentally changes the nature of the drug's effects. MDMA increases positive mood, but it also shares some effects with the classic psychedelics, such as changing the perceived meaning of thoughts and experiences.[4,5] Most important, MDMA increases empathy for the self and others[6,7] and the tolerability of facing emotionally distressing memories or experiences, such as one's "worst" memories or social rejection.[8,9]
    Neuroimaging studies in healthy individuals have demonstrated that MDMA reduces amygdala activity,[10]a possible contributor to greater ease in facing emotionally upsetting material. MDMA increases levels of the affiliative neurohormone oxytocin, a finding also not shared with stimulants.[11,12] This specific type of "feeling into" or "staying with" painful emotions and memories is a key element in established psychotherapies for PTSD, including prolonged exposure therapy. Although such treatments as prolonged exposure can be successful on their own, they also have high drop-out rates and many individuals fail to adequately respond.[13,14,15,16,17]
    It is also notable that healthy controls and people with PTSD report both increased and decreased anxiety after MDMA.[5,18,19,20] This suggests that like many other psychoactive substances, the effects of MDMA are at least partially dependent on the situation of use and the user's mindset—or set and setting.
    Clinical observations and participant reports from clinical trials of MDMA-assisted psychotherapy are contrary to Lieberman's suggestion that MDMA used in therapy is "more likely to produce either euphoria or other types of analgesic-type activity than a genuine therapeutic effect at whatever the underlying pathophysiology of the illness is." MDMA ingested in the context of an 8-hour psychotherapy session is not going to produce the same extent or type of euphoria that might occur at a party or nightclub, because the person is undergoing nondirected processing of traumatic experiences. In fact, many patients feel no euphoria at all; one clinical trial participant who had good therapeutic responses to MDMA-assisted psychotherapy nonetheless said, "I don't know why they call this 'ecstasy.'"
    MDMA-assisted therapy consists of administering the drug a small number of times, often no more than three, during extended psychotherapy sessions occurring at approximately 1-month intervals.[21,22,23,24] Participants are screened for contraindicated medical and psychiatric disorders before enrollment, and MDMA is not given as a take-home dose and never administered daily. For these reasons, the risk for dependence and tolerance with MDMA therapy in controlled settings is low. Published findings[21] from MAPS-sponsored studies indicate that very few participants have sought out "ecstasy" beyond the confines of the psychotherapeutic setting, and no one reported adverse events related to ecstasy use or abuse. This suggests that worries over tolerance and addiction of MDMA used in medical contexts are unsupported. Our continued examination of data collected from phase 2 studies suggests that the risk for problematic use of "ecstasy" after study participation is very low.
    A Bias Toward a Beneficial Treatment

    Bias is hardly unique to research with psychoactive substances, and is addressed by a willingness to share data and findings. It is entirely expected that an organization investing the additional time and money needed to study the most restrictively regulated substances will hold a bias in favor of the treatment; why else go through trouble to address multiple regulatory agencies and additional hurdles to support and conduct these studies?

    MAPS believes that MDMA has potential to help people with PTSD, in part on the basis of narrative accounts of the use of MDMA in therapy sessions before its designation as schedule 1 in 1985. MAPS follows FDA and good clinical practice guidelines for drug development programs in the same manner as all pharmaceutical drug trial sponsors. MAPS-sponsored trials are carried out at independent sites, either clinics or university laboratories. Bias is minimized by blinding of participants and therapy teams to treatment group assignment, and also by having independent raters not present during therapy sessions administer outcome measures. Findings from six phase 2 studies showed that the beneficial effects of treatment were attained across multiple sites within and outside of the United States, therapy teams, and PTSD from different types of traumatic experiences. Publications featuring results from these six studies are being prepared for peer-reviewed journal articles.

    Unlike most pharmaceutical companies, MAPS is a nonprofit organization that relies entirely on private donations for trials of MDMA, cannabis, and other psychedelic agents. If MDMA becomes an FDA-approved medication in the future, MAPS Public Benefit Corporation will be responsible for the sale of the drug to trained providers. As with all public benefit corporations, decisions on drug pricing and company directives will be based first on societal and environmental impact, not solely on company profits. All financial reports are currently posted on maps.org. Transparency will continue for MAPS and its fully owned subsidiary, MAPS Public Benefit Corporation.

    We fully agree with Dr Lieberman's call for further rigorous investigations to define the safety and therapeutic potential of MDMA and other psychedelic substances across large samples. Multisite phase 3 trials of MDMA-assisted psychotherapy have been cleared by the FDA through a Special Protocol Assessment program and will commence in spring 2018. If safety and efficacy results are replicated, MDMA therapy could be a new treatment option by 2021.

    When assessing the use of any drugs, the risk/benefit profile for clinical use must be evaluated separately from risks associated with consumption of substances of unknown purity by unscreened individuals in nonmedical settings. Drug policy discussions addressing the criminalization of "feel-good substances," as Dr Lieberman describes recreational use of psychoactives, are completely independent of clinical investigations and should not be confused with the pursuit to understand the potential therapeutic application for life-threatening disorders, such as PTSD.
    If you want to find the secrets of the universe, think in terms of energy, frequency and vibration. Nicola Tesla


    MLK jr. "I am not saying that there is a conscious move toward socialism, not even by labor, the move is certainly unconscious. But there is a definite move away from capitalism, whether we conceive of it as conscious or unconscious Capitalism finds herself like a losing football team in the last quarter trying all types of tactics to survive."

  2. The Following 2 Users Say Thank You to Big Dummy For This Useful Post:

    HawkTheSlayer (05-10-2018),nonsqtr (05-10-2018)

  3. #2
    Alumni Member and VIP Forum Donor
    V.I.P
    Achievements:
    50000 Experience PointsSocialRecommendation Second ClassOverdriveTagger First ClassCreated Blog entryVeteran
    Overall activity: 99.7%

    HawkTheSlayer's Avatar
    Join Date
    Jul 2015
    Location
    Acadiana
    Posts
    26,090
    Thanks
    57,384
    Thanked: 34,730
    Rep Power
    21474866
    It may be proven to be beneficial for some.

    I would be careful giving it to women, though.
    They may suddenly feel like going to the club and dancing non-stop until 4 in the morning.
    Last edited by HawkTheSlayer; 05-10-2018 at 06:12 PM.
    Today we live. Tomorrow we die.
    "Evil is da Devil minus da D"

  4. The Following User Says Thank You to HawkTheSlayer For This Useful Post:

    Big Dummy (05-10-2018)

  5. #3
    V.I.P. V.I.P Achievements:
    Created Blog entry50000 Experience PointsSocialYour first GroupRecommendation First ClassVeteran
    Overall activity: 32.0%

    Montana's Avatar
    Join Date
    May 2015
    Location
    some where in time
    Posts
    8,282
    Thanks
    15,665
    Thanked: 9,243
    Blog Entries
    12
    Rep Power
    21474848
    Better yet may lead to all night sex
    Quote Originally Posted by HawkTheSlayer View Post
    It may be proven to be beneficial for some.

    I would be careful giving it to women, though.
    They may suddenly feel like going to the club and dancing non-stop until 4 in the morning.
    Montana

  6. The Following 2 Users Say Thank You to Montana For This Useful Post:

    Big Dummy (05-10-2018),HawkTheSlayer (05-10-2018)

  7. #4
    Alumni Member and VIP Forum Donor
    V.I.P
    Achievements:
    50000 Experience PointsSocialRecommendation Second ClassOverdriveTagger First ClassCreated Blog entryVeteran
    Overall activity: 99.7%

    HawkTheSlayer's Avatar
    Join Date
    Jul 2015
    Location
    Acadiana
    Posts
    26,090
    Thanks
    57,384
    Thanked: 34,730
    Rep Power
    21474866
    Quote Originally Posted by Montana View Post
    Better yet may lead to all night sex
    Montana..Montana..Montana...... sex is great at relieving stress whether post traumatic or immediate.

    I have two friends who are brothers. One is a MD. The other is a pharmacist.
    A street pharmacist. He's long retired. His brother is still working.

    By the time his brother got out of medical school, he had purchased 500 acres of land and built a mansion. Complete with a game room, cypress interior and cabinets, 5 piece molding around all interior walls. Nice pool too.

    Stress takes on many forms. I'm all for relieving stress without debilitating an individual.
    What works for one person , may not work for another.

    Old people have to be very careful when relieving stress with all night sex.
    Throwing out a back or knee can cause more stress.

    However, a pulled muscle can be very stress relieving.
    Today we live. Tomorrow we die.
    "Evil is da Devil minus da D"

  8. The Following User Says Thank You to HawkTheSlayer For This Useful Post:

    Montana (05-10-2018)

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •